What is essentially happening, poorly guided funds sold, funds who understand biotech and drugs, bought
retail was driven out long ago and the news was not a beacon to retail, to come in. This was and is, institutional play.
Long ago, when genetic and oligo antisense began development, large pharma took notice and got involved. There is no denying this fact.
Now, today, you have a transcript to review and I suggest you look long and hard at it. For those who sold on Friday, and prior, I suggest, there is more reason now for the stock to go back to $ 15. Just my opinion, however, the biggest fear is "does it work" and the way the partners have spoken, its very clear, they are very convinced this version of antisense makes a very, very big difference. Take special note to the part of the transcript where they discuss moving out from the hyper-indication to more common indications in millions of obese individuals.
I wonder to myself, are there forces at play here, to scare away retail from buying and holding long? Could be. The funds want it all to themselves, and large pharma wants and needs to have a piece, to have CONTROL. Think.
I'm sorry for the fifth generation of newbies to "promising" antisense future. In 1997 I warned all and did save a lot of investors their families money. The same dark side-effects remain and will be discovered again by the next wave of hopefuls. Sad. Grab a few shares of Vical.
No, you are not. You are just a liar, relying on an after-the-fact statistic that you know will change in time. Maybe sooner than you think. I agree, there were many who took advantage of investors under the guise of "antisense" *working* and they all seem to have a single association with another, who posted on this board. A lawyer who tracks to the hedge fund which tracks to certain political campaign contributions. You belong in their company. Enjoy !